Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma

Oncogene

Volumn 25, Issue 7, 2006, Pages 998-1007

  Gladden, A B ^a,c   Woolery, R ^a   Aggarwal, P ^a   Wasik, M A ^b   Diehl, J A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; CDK4; Cyclin D1; Mantle cell lymphoma

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P19; PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CELL CYCLE S PHASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; LYMPHOCYTE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL NUCLEUS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; IMMUNOGLOBULIN M; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; MICE; MICE, TRANSGENIC; MUTATION; S PHASE;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 33244481730     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209147     Document Type: Article

References (46)

1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S et al. (1985). Nature 318: 533-538.
2. Akiyama N, Tsuruta H, Sasaki H, Sakamoto H, Hamaguchi M, Ohmura Y et al. (1994). Cancer Res 54: 377-379.
3. Alt FW, Yancopoulos GD, Blackwell TK, Wood C, Thomas E, Boss M et al. (1984). EMBO J 3: 1209-1219.
4. Alt JR, Cleveland JL, Hannink M, Diehl JA. (2000). Genes Dev 14: 3102-3114.
5. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. (1997). Blood 89: 2067-2078.
6. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. (1992). Nature 359: 552-554.
7. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. (1994). EMBO J 13: 2124-2130.
8. Borzillo GV, Sherr CJ. (1989). Mol Cell Biol 9: 3973-3981.
9. Bosch F, Lopez-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA et al. (1998). Cancer 82: 567-575.
10. Chen WG, Chen YY, Kamel OW, Koo CH, Weiss LM. (1996). Lab Invest 75: 519-527.
11. Diehl JA, Cheng M, Roussel MF, Sherr CJ. (1998). Genes Dev 12: 3499-3511.
12. Diehl JA, Sherr CJ. (1997). Mol Cell Biol 17: 7362-7374.
13. Diehl JA, Zindy F, Sherr CJ. (1997). Genes Dev 11: 957-972.
14. Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL. (2001a). Mol Cell Biol 21: 7653-7662.
15. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. (1999). Genes Dev 13: 2658-2669.
16. Eischen CM, Woo D, Roussel MF, Cleveland JL. (2001b). Mol Cell Biol 21: 5063-5070.
17. Fanidi A, Harrington EA, Evan GI. (1992). Nature 359: 554-556.
18. Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E et al. (2004). Mol Cancer Ther 3: 1427-1438.
19. Gladden AB, Diehl JA. (2003). J Biol Chem 278: 9754-9760.
20. Gronbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P. (2002). Blood 100: 1430-1437.
21. Hall M, Peters G. (1996). Adv Cancer Res 68: 67-108.
22. Hernandez L, Hernandez S, Bea S, Pinyol M, Ferrer A, Bosch F et al. (1999). Leukemia 13: 2087-2093.
23. Hosokawa Y, Joh T, Maeda Y, Arnold A, Seto M. (1999). Int J Cancer 81: 616-619.
24. Howe D, Lynas C. (2001). Haematologica 86: 563-569.
25. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS et al. (1997). Genes Dev 11: 847-862.
26. Lai R, McDonnell TJ, O'Connor SL, Medeiros LJ, Oudat R, Keating M et al. (2002). Leuk Res 26: 849-855.
27. Levine AJ. (1997). Cell 88: 323-331.
28. Lovec H, Grzeschiczek A, Kowalski MB, Moroy T. (1994a). EMBO J 13: 3487-3495.
29. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. (1994b). Oncogene 9: 323-326.
30. Lu F, Gladden AB, Diehl JA. (2003). Cancer Res 63: 7056-7061.
31. Martinez N, Camacho FI, Algara P, Rodriguez A, Dopazo A, Ruiz-Ballesteros E, Martin P et al. (2003). Cancer Res 63: 8226-8232.
32. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. (1994). Mol Cell Biol 14: 2066-2076.
33. McDonnell TJ, Korsmeyer SJ. (1991). Nature 349: 254-256.
34. Nagy B, Lundan T, Larramendy ML, Aalto Y, Zhu Y, Niini T et al. (2003). Br J Haematol 120: 434-441.
35. Noelle RJ, Snow EC. (1990). Immunol Today 11: 361-368.
36. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF et al. (1993). Genes Dev 7: 1559-1571.
37. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. (2003). Cancer Cell 3: 185-197.
38. Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I et al. (1992). Oncogene 7: 1401-1406.
39. Sherr CJ. (1996). Science 274: 1672-1677.
40. Sofer-Levi Y, Resnitzky D. (1996). Oncogene 13: 2431-2437.
41. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z et al. (2003). J Biol Chem 278: 30339-30347.
42. Strasser A, Harris AW, Cory S. (1993). Oncogene 8: 1-9.
43. Uchimaru K, Endo K, Fujinuma H, Zukerberg L, Arnold A, Motokura T. (1996). Jpn J Cancer Res 87: 459-465.
44. Zhang H, Hannon GJ, Beach D. (1994). Genes Dev 8: 1750-1758.
45. Zhou P, Levy NB, Xie H, Qian L, Lee CY, Gascoyne RD et al. (2001). Blood 91: 3902-3909.
46. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ et al. (1998). Genes Dev 12: 2424-2433.